{
  "DOI": "10.1186/s40246-018-0171-5",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-018-0171-5",
  "alternative-id": [
    "171"
  ],
  "article-number": "39",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "9 March 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "30 July 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "13 August 2018"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Routine procedure included signing a written informed consent to genetic testing (including anonymized disclosure of the data) from each patient, approved by the Ethics Committee from CEMIC and a Pretest Counseling for Susceptibility Testing (purpose of testing), as described in the American Society of Clinical Oncology Policy Statement Update."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "SG is the medical director in AstraZeneca Argentina and Uruguay MC. LS is the diagnosis manager in AstraZeneca Argentina MC. IDP is the oncology medical manager in AstraZeneca Argentina and Uruguay MC. The other authors declare that they have no competing interest."
    },
    {
      "group": {
        "label": "Publisher’s Note",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Cardoso",
      "given": "Florencia C.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Goncalves",
      "given": "Susana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mele",
      "given": "Pablo G.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Liria",
      "given": "Natalia C.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sganga",
      "given": "Leonardo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Diaz Perez",
      "given": "Ignacio",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Podesta",
      "given": "Ernesto J.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-6342-3663",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Solano",
      "given": "Angela R.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2018,
        8,
        13
      ]
    ],
    "date-time": "2018-08-13T12:39:37Z",
    "timestamp": 1534163977000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        8,
        12
      ]
    ],
    "date-time": "2019-08-12T23:13:34Z",
    "timestamp": 1565651614000
  },
  "funder": [
    {
      "award": [
        "Res. 0515"
      ],
      "name": "Instituto Nacional del Cáncer, Ministerio de Salud de la República Argentina"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        4
      ]
    ],
    "date-time": "2024-01-04T11:20:29Z",
    "timestamp": 1704367229737
  },
  "is-referenced-by-count": 16,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2018,
        8,
        13
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2018,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            8,
            13
          ]
        ],
        "date-time": "2018-08-13T00:00:00Z",
        "timestamp": 1534118400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-018-0171-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-018-0171-5/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-018-0171-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2018,
        8,
        13
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2018,
        8,
        13
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/jcb.240590926",
      "author": "WJ Hoskins",
      "doi-asserted-by": "publisher",
      "first-page": "189",
      "journal-title": "J Cell Biochem Suppl",
      "key": "171_CR1",
      "unstructured": "Hoskins WJ. Prospective on ovarian cancer: why prevent? J Cell Biochem Suppl. 1995;23:189–99.",
      "volume": "23",
      "year": "1995"
    },
    {
      "DOI": "10.1016/S0140-6736(10)60893-8",
      "author": "MW Audeh",
      "doi-asserted-by": "publisher",
      "first-page": "245",
      "issue": "9737",
      "journal-title": "Lancet",
      "key": "171_CR2",
      "unstructured": "Audeh MW, Carmichael J, Penson RT, Friedlander M, Powell B, Bell-McGuinn KM, Scott C, Weitzel JN, Oaknin A, Loman N, et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet. 2010;376(9737):245–51.",
      "volume": "376",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJMoa1105535",
      "author": "J Ledermann",
      "doi-asserted-by": "publisher",
      "first-page": "1382",
      "issue": "15",
      "journal-title": "N Engl J Med",
      "key": "171_CR3",
      "unstructured": "Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott C, Meier W, Shapira-Frommer R, Safra T, et al. Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N Engl J Med. 2012;366(15):1382–92.",
      "volume": "366",
      "year": "2012"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-15-0887",
      "author": "G Kim",
      "doi-asserted-by": "publisher",
      "first-page": "4257",
      "issue": "19",
      "journal-title": "Clin Cancer Res",
      "key": "171_CR4",
      "unstructured": "Kim G, Ison G, McKee AE, Zhang H, Tang S, Gwise T, Sridhara R, Lee E, Tzou A, Philip R, et al. FDA approval summary: olaparib monotherapy in patients with deleterious germline BRCA-mutated advanced ovarian cancer treated with three or more lines of chemotherapy. Clin Cancer Res. 2015;21(19):4257–61.",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ejca.2016.03.005",
      "author": "JA Ledermann",
      "doi-asserted-by": "publisher",
      "first-page": "49",
      "journal-title": "Eur J Cancer",
      "key": "171_CR5",
      "unstructured": "Ledermann JA, Drew Y, Kristeleit RS. Homologous recombination deficiency and ovarian cancer. Eur J Cancer. 2016;60:49–58.",
      "volume": "60",
      "year": "2016"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-14-1816",
      "author": "Q Zhong",
      "doi-asserted-by": "publisher",
      "first-page": "211",
      "issue": "1",
      "journal-title": "Clin Cancer Res",
      "key": "171_CR6",
      "unstructured": "Zhong Q, Peng HL, Zhao X, Zhang L, Hwang WT. Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis. Clin Cancer Res. 2015;21(1):211–20.",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ygyno.2005.06.058",
      "author": "YT Kim",
      "doi-asserted-by": "publisher",
      "first-page": "585",
      "issue": "3",
      "journal-title": "Gynecol Oncol",
      "key": "171_CR7",
      "unstructured": "Kim YT, Nam EJ, Yoon BS, Kim SW, Kim SH, Kim JH, Kim HK, Koo JS, Kim JW. Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma. Gynecol Oncol. 2005;99(3):585–90.",
      "volume": "99",
      "year": "2005"
    },
    {
      "DOI": "10.1002/cncr.29707",
      "author": "I Sakamoto",
      "doi-asserted-by": "publisher",
      "first-page": "84",
      "issue": "1",
      "journal-title": "Cancer",
      "key": "171_CR8",
      "unstructured": "Sakamoto I, Hirotsu Y, Nakagomi H, Ouchi H, Ikegami A, Teramoto K, Amemiya K, Mochizuki H, Omata M. BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer. Cancer. 2016;122(1):84–90.",
      "volume": "122",
      "year": "2016"
    },
    {
      "DOI": "10.1002/1098-1004(200007)16:1\u003c88::AID-HUMU16\u003e3.0.CO;2-G",
      "author": "US Khoo",
      "doi-asserted-by": "publisher",
      "first-page": "88",
      "issue": "1",
      "journal-title": "Hum Mutat",
      "key": "171_CR9",
      "unstructured": "Khoo US, Ngan HY, Cheung AN, Chan KY, Lu J, Chan VW, Lau S, Andrulis IL, Ozcelik H. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Hum Mutat. 2000;16(1):88–9.",
      "volume": "16",
      "year": "2000"
    },
    {
      "DOI": "10.1002/humu.9015",
      "author": "US Khoo",
      "doi-asserted-by": "publisher",
      "first-page": "307",
      "issue": "3",
      "journal-title": "Hum Mutat",
      "key": "171_CR10",
      "unstructured": "Khoo US, Chan KY, Cheung AN, Xue WC, Shen DH, Fung KY, Ngan HY, Choy KW, Pang CP, Poon CS, et al. Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. Hum Mutat. 2002;19(3):307–8.",
      "volume": "19",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.ygyno.2011.10.027",
      "author": "AO Rodriguez",
      "doi-asserted-by": "publisher",
      "first-page": "236",
      "issue": "2",
      "journal-title": "Gynecol Oncol",
      "key": "171_CR11",
      "unstructured": "Rodriguez AO, Llacuachaqui M, Pardo GG, Royer R, Larson G, Weitzel JN, Narod SA. BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia. Gynecol Oncol. 2012;124(2):236–43.",
      "volume": "124",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10549-015-3629-3",
      "author": "J Dutil",
      "doi-asserted-by": "publisher",
      "first-page": "441",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "171_CR12",
      "unstructured": "Dutil J, Golubeva VA, Pacheco-Torres AL, Diaz-Zabala HJ, Matta JL, Monteiro AN. The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective. Breast Cancer Res Treat. 2015;154(3):441–53.",
      "volume": "154",
      "year": "2015"
    },
    {
      "DOI": "10.18632/oncotarget.10814",
      "author": "AR Solano",
      "doi-asserted-by": "publisher",
      "first-page": "60487",
      "issue": "36",
      "journal-title": "Oncotarget",
      "key": "171_CR13",
      "unstructured": "Solano AR, Cardoso FC, Romano V, Perazzo F, Bas C, Recondo G, Santillan FB, Gonzalez E, Abalo E, Viniegra M, et al. Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice. Oncotarget. 2017;8(36):60487–95.",
      "volume": "8",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2015.63.0996",
      "author": "ME Robson",
      "doi-asserted-by": "publisher",
      "first-page": "3660",
      "issue": "31",
      "journal-title": "J Clin Oncol",
      "key": "171_CR14",
      "unstructured": "Robson ME, Bradbury AR, Arun B, Domchek SM, Ford JM, Hampel HL, Lipkin SM, Syngal S, Wollins DS, Lindor NM. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2015;33(31):3660–7.",
      "volume": "33",
      "year": "2015"
    },
    {
      "author": "JM Marqués",
      "key": "171_CR15",
      "unstructured": "Marqués JM, Repetto L, Guggeri V, Russo E, García A, Agorio A, Torres A, Azambuja CJ. Sample ID quality control and methodological improvements for NGS gene panels. In: 65th Annual Meeting of The American Society of Human Genetics. (Abst.1959F); 2015.",
      "volume-title": "65th Annual Meeting of The American Society of Human Genetics. (Abst.1959F)",
      "year": "2015"
    },
    {
      "key": "171_CR16",
      "unstructured": "ClinVar, National Center for Biotechnology \n                    http://www.ncbi.nlm.nih.gov/clinvar/\n                    \n                  . Accesed 29 Dec 2017."
    },
    {
      "key": "171_CR17",
      "unstructured": "Leiden Open Variation Database 3.0. \n                    https://databases.lovd.nl/shared/genes\n                    \n                  . Accesed 29 Dec 2017."
    },
    {
      "key": "171_CR18",
      "unstructured": "Universal Mutation Database \n                    http://www.umd.be/\n                    \n                  . Accesed 29 Dec 2017."
    },
    {
      "key": "171_CR19",
      "unstructured": "Leiden Open Variation Database (Chapter for Argentina). \n                    http://ar.lovd.org\n                    \n                  . Accesed 29 Dec 2017."
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "171_CR20",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1186/2193-1801-1-20",
      "author": "AR Solano",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "SpringerPlus",
      "key": "171_CR21",
      "unstructured": "Solano AR, Aceto GM, Delettieres D, Veschi S, Neuman MI, Alonso E, Chialina S, Chacon RD, Renato MC, Podesta EJ. BRCA1 and BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin. SpringerPlus. 2012;1:20.",
      "volume": "1",
      "year": "2012"
    },
    {
      "DOI": "10.1001/jama.2014.5985",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "1347",
      "issue": "13",
      "journal-title": "JAMA",
      "key": "171_CR22",
      "unstructured": "Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313(13):1347–61.",
      "volume": "313",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10549-009-0596-6",
      "author": "GM Aceto",
      "doi-asserted-by": "publisher",
      "first-page": "671",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "171_CR23",
      "unstructured": "Aceto GM, Solano AR, Neuman MI, Veschi S, Morgano A, Malatesta S, Chacon RD, Pupareli C, Lombardi M, Battista P, et al. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer. Breast Cancer Res Treat. 2010;122(3):671–83.",
      "volume": "122",
      "year": "2010"
    },
    {
      "DOI": "10.1093/annonc/mdq577",
      "author": "DJ Gallagher",
      "doi-asserted-by": "publisher",
      "first-page": "1127",
      "issue": "5",
      "journal-title": "Ann Oncol",
      "key": "171_CR24",
      "unstructured": "Gallagher DJ, Konner JA, Bell-McGuinn KM, Bhatia J, Sabbatini P, Aghajanian CA, Offit K, Barakat RR, Spriggs DR, Kauff ND. Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Ann Oncol. 2011;22(5):1127–32.",
      "volume": "22",
      "year": "2011"
    },
    {
      "DOI": "10.1093/annonc/mdq628",
      "author": "PM Vencken",
      "doi-asserted-by": "publisher",
      "first-page": "1346",
      "issue": "6",
      "journal-title": "Ann Oncol",
      "key": "171_CR25",
      "unstructured": "Vencken PM, Kriege M, Hoogwerf D, Beugelink S, van der Burg ME, Hooning MJ, Berns EM, Jager A, Collee M, Burger CW, et al. Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients. Ann Oncol. 2011;22(6):1346–52.",
      "volume": "22",
      "year": "2011"
    },
    {
      "DOI": "10.1001/jama.2011.1456",
      "author": "D Yang",
      "doi-asserted-by": "publisher",
      "first-page": "1557",
      "issue": "14",
      "journal-title": "JAMA",
      "key": "171_CR26",
      "unstructured": "Yang D, Khan S, Sun Y, Hess K, Shmulevich I, Sood AK, Zhang W. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA. 2011;306(14):1557–65.",
      "volume": "306",
      "year": "2011"
    },
    {
      "DOI": "10.1200/JCO.2011.39.8545",
      "author": "K Alsop",
      "doi-asserted-by": "publisher",
      "first-page": "2654",
      "issue": "21",
      "journal-title": "J Clin Oncol",
      "key": "171_CR27",
      "unstructured": "Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, Dobrovic A, Birrer MJ, Webb PM, Stewart C, et al. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol. 2012;30(21):2654–63.",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ygyno.2012.03.006",
      "author": "RB Dann",
      "doi-asserted-by": "publisher",
      "first-page": "677",
      "issue": "3",
      "journal-title": "Gynecol Oncol",
      "key": "171_CR28",
      "unstructured": "Dann RB, DeLoia JA, Timms KM, Zorn KK, Potter J, Flake DD 2nd, Lanchbury JS, Krivak TC. BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer. Gynecol Oncol. 2012;125(3):677–82.",
      "volume": "125",
      "year": "2012"
    },
    {
      "DOI": "10.1093/jnci/djs494",
      "author": "JR McLaughlin",
      "doi-asserted-by": "publisher",
      "first-page": "141",
      "issue": "2",
      "journal-title": "J Natl Cancer Inst",
      "key": "171_CR29",
      "unstructured": "McLaughlin JR, Rosen B, Moody J, Pal T, Fan I, Shaw PA, Risch HA, Sellers TA, Sun P, Narod SA. Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2. J Natl Cancer Inst. 2013;105(2):141–8.",
      "volume": "105",
      "year": "2013"
    },
    {
      "DOI": "10.1002/ijc.30633",
      "author": "T Shi",
      "doi-asserted-by": "publisher",
      "first-page": "2051",
      "issue": "9",
      "journal-title": "Int J Cancer",
      "key": "171_CR30",
      "unstructured": "Shi T, Wang P, Xie C, Yin S, Shi D, Wei C, Tang W, Jiang R, Cheng X, Wei Q, et al. BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer. Int J Cancer. 2017;140(9):2051–9.",
      "volume": "140",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ygyno.2012.05.001",
      "author": "DM Hyman",
      "doi-asserted-by": "publisher",
      "first-page": "224",
      "issue": "2",
      "journal-title": "Gynecol Oncol",
      "key": "171_CR31",
      "unstructured": "Hyman DM, Long KC, Tanner EJ, Grisham RN, Arnold AG, Bhatia J, Phillips MF, Spriggs DR, Soslow RA, Kauff ND, et al. Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma. Gynecol Oncol. 2012;126(2):224–8.",
      "volume": "126",
      "year": "2012"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-13-2287",
      "author": "KP Pennington",
      "doi-asserted-by": "publisher",
      "first-page": "764",
      "issue": "3",
      "journal-title": "Clin Cancer Res",
      "key": "171_CR32",
      "unstructured": "Pennington KP, Walsh T, Harrell MI, Lee MK, Pennil CC, Rendi MH, Thornton A, Norquist BM, Casadei S, Nord AS, et al. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res. 2014;20(3):764–75.",
      "volume": "20",
      "year": "2014"
    },
    {
      "author": "A Fedier",
      "first-page": "1169",
      "issue": "5",
      "journal-title": "Int J Oncol",
      "key": "171_CR33",
      "unstructured": "Fedier A, Steiner RA, Schwarz VA, Lenherr L, Haller U, Fink D. The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells. Int J Oncol. 2003;22(5):1169–73.",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-07-4953",
      "author": "B Evers",
      "doi-asserted-by": "publisher",
      "first-page": "3916",
      "issue": "12",
      "journal-title": "Clin Cancer Res",
      "key": "171_CR34",
      "unstructured": "Evers B, Drost R, Schut E, de Bruin M, van der Burg E, Derksen PW, Holstege H, Liu X, van Drunen E, Beverloo HB, et al. Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin. Clin Cancer Res. 2008;14(12):3916–25.",
      "volume": "14",
      "year": "2008"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-018-0171-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "12"
}